Skip to main content

/ Groups/ Dr. Goodyear

Dr. Goodyear

Dr. Goodyear is passionate about all things wellness. In particular, Dr. Goodyear is the Medical Director at Brio-Medical in Arizona to take on one of the greatest obstacles to long-term wellness in the Western hemisphere--cancer. In addition, Dr. Goodyear is the Chairman of the Scientific Medical Advisory Board of the Vitamin C International Consortium Institute (VCICI)

Join this group

Sort By: Most Recent | Popular Filter: All | Bookmarks | Topics Simple Middle

Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug t... - 0 views

link.springer.com/...s00204-021-03025-z

P-glycoprotein CYP450 multi-drug resistance ivermectin MDR

shared by Nathan Goodyear on 31 Jan 24 - No Cached

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor - PubMed - 0 views

pubmed.ncbi.nlm.nih.gov/8949985

MDR ivermectin cancer P-glycoprotein

shared by Nathan Goodyear on 31 Jan 24 - No Cached

Reversal of P-glycoprotein-associated multidrug resistance by ivermectin - PubMed - 0 views

pubmed.ncbi.nlm.nih.gov/8960059

resistance" cancer P-glycoprotein drug multi MDR ivermectin

shared by Nathan Goodyear on 31 Jan 24 - No Cached

Ivermectin, 'Wonder drug' from Japan: the human use perspective - PMC - 0 views

www.ncbi.nlm.nih.gov/...PMC3043740

shared by Nathan Goodyear on 31 Jan 24 - No Cached

Ivermectin Mectizan - American Chemical Society - 0 views

www.acs.org/...ivermectin-mectizan.html

shared by Nathan Goodyear on 31 Jan 24 - No Cached

Biomolecules | Free Full-Text | Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immu... - 0 views

www.mdpi.com/1338

SARS-CoV-2 IgG4

shared by Nathan Goodyear on 31 Jan 24 - No Cached

IgG4-related disease and prostate cancer: A case report and review of the literature - ... - 0 views

www.sciencedirect.com/...S2214442023002243

cancer IgG4 immune metastasis escape"

shared by Nathan Goodyear on 17 Jan 24 - No Cached

Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway -... - 0 views

www.ncbi.nlm.nih.gov/...PMC7662796

pancreatic cancer CBD P-21 THC KRAS

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Nathan Goodyear on 30 Jan 24

THC:CBD target pancreatic cancer which expresses KRAS mutation appx 90% of time.

<div class="cArrow"> </div><div class="cContentInner">THC:CBD target pancreatic cancer which expresses KRAS mutation appx 90% of time.</div>

...

Cancel

Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Meta... - 0 views

pubs.acs.org/...acs.jproteome.0c00394

pancreatic cancer berberine

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers solutions -... - 0 views

pubmed.ncbi.nlm.nih.gov/23989704

LR NS Magnesium

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Nathan Goodyear on 30 Jan 24

No incompatibility

<div class="cArrow"> </div><div class="cContentInner">No incompatibility </div>

...

Cancel

The Pharmacokinetics and Interactions of Ivermectin in Humans-A Mini-review | The AAPS ... - 0 views

link.springer.com/...s12248-007-9000-9

cancer ivermectin iver pharmacokinetics

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Cureus | Identifying the Toxidrome of Ivermectin Toxicity | Article - 0 views

www.cureus.com/...xidrome-of-ivermectin-toxicity

ivermectin cancer

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Nathan Goodyear on 30 Jan 24

0.2 to 0.4 mg/kg daily dose

<div class="cArrow"> </div><div class="cContentInner">0.2 to 0.4 mg/kg daily dose</div>

...

Cancel

Ivermectin systemic availability in adult volunteers treated with different oral pharma... - 0 views

www.sciencedirect.com/...S0753332223001798

cancer ivermectin

shared by Nathan Goodyear on 30 Jan 24 - No Cached

The relative systemic availability of ivermectin after administration as capsule, table... - 0 views

pubmed.ncbi.nlm.nih.gov/3234475

ivermectin cancer

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in he... - 0 views

pubmed.ncbi.nlm.nih.gov/12362927

ivermectin cancer

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure | bioRxiv - 0 views

www.biorxiv.org/...2023.11.13.566860v2

immune escape COVID spike protein immune evasion SARS-CoV-2 JN.1 COVID19 COVID-19

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug t... - 0 views

www.ncbi.nlm.nih.gov/...PMC7956433

Ivermectin toxicity

shared by Nathan Goodyear on 30 Jan 24 - No Cached

Resveratrol in Cancer Treatment with a Focus on Breast Cancer - PubMed - 0 views

pubmed.ncbi.nlm.nih.gov/35713130

resveratrol breast cancer

shared by Nathan Goodyear on 29 Jan 24 - No Cached

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-A... - 0 views

www.ncbi.nlm.nih.gov/...PMC6413140

lupron anti-inflammatory anti-angiogenic lupron alternative endometriosis angiogenesis resveratrol

shared by Nathan Goodyear on 29 Jan 24 - No Cached

Therapeutic effects and molecular mechanisms of resveratrol | IJWH - 0 views

www.dovepress.com/reviewed-fulltext-article-IJWH

lupron lupron alternative resveratrol

shared by Nathan Goodyear on 29 Jan 24 - No Cached

« First ‹ Previous 261 - 280 of 11108 Next › Last »

Showing 20▼ items per page

Join this group

View AllMost Active Members

View AllTop 10 Tags